Evidence map›Paper›PMID 42011136›Full record

ArticleChembiochem : a European journal of chemical biology2026

Heterologous Production of Barnesin A, an NRPS-PKS Hybrid Containing a Rare Vinylogous Arginine Moiety.

Sven Balluff, Marie Dayras, Christine Beemelmanns

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sven BalluffAntiinfectives from Microbiota, Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany.
Marie DayrasAntiinfectives from Microbiota, Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany.ORCID 0000-0002-2598-7943
Christine BeemelmannsAntiinfectives from Microbiota, Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany.ORCID 0000-0002-9747-3423

Funding

Horizon 2020 Framework Programme 802736
6 · The paper itself

Abstract

Natural products containing vinylogous amino acids are rarely found in nature and often possess significant biological activity. Barnesin A was the first NP reported from an anaerobic bacterium (Sulfurospirillum barnesii) postulated to be biosynthesized by a nonribosomal peptide synthetase (NRPS) polyketide synthases (PKS) hybrid. Containing a vinylogous arginine moiety, the lipodipeptide exhibited nanomolar inhibitory activity against cysteine proteases. While a putative NRPS-PKS hybrid biosynthetic gene cluster (brn) was identified and a trans-acting acyltransferase (trans-AT) domain was postulated, experimental validation remained an open question. Here, we report the production of barnesin A by heterologous expression of the trans-AT domain-dependent NRPS-PKS gene cluster in Escherichia coli. Our findings indicate that the native primary metabolism-derived malonyl CoA-acyl carrier protein transacylase homolog (FabD) functions as a trans-AT in the biosynthesis pathway, while the NRPS-PKS megaenzyme exhibited strict selectivity toward its native phosphopantetheinyl transferase. Metabolome mining further allowed for the description of previously unreported barnesin congeners. The results of this study enabled the establishment of a biosynthetic platform for the generation of novel lipopeptidic vinylogous protease inhibitors.

Indexed as

ArgininePeptide SynthasesPolyketide SynthasesEscherichia coliMultigene FamilyArgininenon-ribosomal peptide synthasePeptide SynthasesPolyketide Synthasesbiosynthesisheterologous expressionnatural productsnonribosomal peptideprotease inhibitorvinylogous amino acid

Identifiers

PMID42011136
PMCPMC13096860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.